Lisata Therapeutics has acquired Marea Therapeutics, a biotech focused on cardioendocrine diseases, through a stock-for-stock deal. The transaction includes a private placement expected to raise about $225 million, which Lisata will use to fund clinical trials for Marea's drug candidates targeting severe hypertriglyceridemia and acromegaly. These trials are set to report results in late 2027. Post-acquisition, Marea's shareholders will hold the majority stake, while Lisata's prior shareholders and new investors will own smaller portions. This move expands Lisata's focus and resources toward advancing important cardioendocrine treatments.
Lisata Therapeutics' acquisition of Marea Therapeutics is the subject here, with Pluang's Health-sector market data providing context. Of 91 priced Health-sector US stocks tradable on Pluang, 65 rose and 26 fell today. Notable movers include DNA at USD 7.77 (+10.06%), CRSP at USD 56.74 (+8.69%, with 35% Sell / 65% Buy order activity), and RXRX at USD 3.46 (+8.62%, with 0% Sell / 100% Buy order activity). These figures are as of Sep 17, 2026 23:42 WIB.
US stock markets closed the week with mixed results: the Nasdaq rose 0.46%, while the Dow Jones Industrial Average fell 1.25% and the S&P 500 dipped 0.26%. Treasury yields climbed steadily, with the 10-year Treasury briefly reaching a 24-year high ne...
Ether (ETH) trading on Binance's perpetual market shows a significant bid surplus of $55.9 million, indicating strong buying interest near $2,694.94. Binance's spot market also has a smaller bid surplus of about $1.5 million. However, other platforms...
President Donald Trump signed an executive order permitting the broader use of red-dyed diesel, a cheaper, tax-exempt fuel usually reserved for farms and construction, to help lower soaring fuel prices. This move comes as the US diesel price hit a re...
Amber Group acquired 4.669 million Ethena (ENA) tokens valued at approximately $1.14 million on October 6. This significant transfer highlights Amber Group's growing involvement in the crypto asset market. The move may indicate strategic positioning ...
OCI Global published correspondence with the Dutch retail investors association (VEB) addressing concerns about the NNS offer memorandum and the OCI-Orascom Construction transaction. The discussion covers waiver provisions for tendering shareholders,...
